Lotus Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This page contains a Q&A table for Lotus Pharmaceutical Co Ltd. Jump to the end of this page for potential risks for Lotus Pharmaceutical Co Ltd based on sector, geography and size. If you work at Lotus Pharmaceutical Co Ltd and you would like to licence your ESG aseessment, please get in touch.
Lotus Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 0.0 and governance score of 1.6.
0.5
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1898 | Zota Health Care Ltd | 0.7 | Low |
1898 | cbdMD Inc | 0.7 | Low |
1924 | Lotus Pharmaceutical Co Ltd | 0.5 | Low |
1924 | Beximco Pharmaceuticals Ltd | 0.5 | Low |
1924 | Acucela Inc | 0.5 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Lotus Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Lotus Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Lotus Pharmaceutical Co Ltd report the average age of the workforce?
Does Lotus Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Lotus Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Lotus Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Lotus Pharmaceutical Co Ltd offer flexible work?
Does Lotus Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Lotus Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Lotus Pharmaceutical Co Ltd conduct supply chain audits?
Does Lotus Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Lotus Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Lotus Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Lotus Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Lotus Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Lotus Pharmaceutical Co Ltd disclose water use targets?
Does Lotus Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Lotus Pharmaceutical Co Ltd have a product recall in the last two years?
Does Lotus Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Lotus Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Lotus Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Lotus Pharmaceutical Co Ltd disclose parental leave metrics?
Does Lotus Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Lotus Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Lotus Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Lotus Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Lotus Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Lotus Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Lotus Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Lotus Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Lotus Pharmaceutical Co Ltd disclose its waste policy?
Does Lotus Pharmaceutical Co Ltd report according to TCFD requirements?
Does Lotus Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Lotus Pharmaceutical Co Ltd disclose energy use targets?
Does Lotus Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Lotus Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Lotus Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.